In the coming weeks and months, I am going to run a series of posts (some interviews, some guest posts) on human cloning, the reproductive type. This is the kind of cloning where you take a person (living or dead) such as, let’s say Lady GaGa or Jesus, and you try to make a duplicate […]
Series on scientific & bioethics leaders discussing human cloning Read More »
Today the Supreme Court agreed to review three cases, none of which were Sherley v Sebelius. What a great day! For those curious, Certiorari Granted (subheading on Supreme Court announcement) means the Court has granted review of these cases. This is wonderful news for patients, the stem cell field, and probably biotech Advanced Cell Technology
Great news as Sherley v Sebelius officially over: Supreme Court Takes a pass Read More »
The buzz topic in the stem cell field right now is whether the U.S. Supreme Court (SCOTUS) will take up the Sherley v Sebelius (S v S) case over the legality of federal funding of embryonic stem cell research in the U.S. The SCOTUS decision as to whether to hear the S v S should
Sherley v Sebelius: Will SCOTUS hear the case? What happens if it does? Read More »
Behind the scenes I get a lot of emails from employers in the stem cell/cell therapy/regenerative medicine fields looking for good prospective employees I might know. At the same time, I get a lot of emails from job seekers asking me to let them know if there are any openings I might know about. I’ve
Stem cell jobs page: free postings for job openings & seekers Read More »
Businessweek just published a very long, interesting article on Celltex by Susan Berfield yesterday. I was happy to talk with Susan at length about the key issues and be quoted in the article. See image at left of two key Celltex leaders, David Eller, CEO of Celltex, and Stan Jones above (Photograph by Thomas Prior
Nuggets and pyrite in Businessweek article on Celltex Read More »
2012 Brazilian Congress on Stem Cells & Cell Therapy, Sao Paulo, Oct 3-6 NYSCF Seventh Annual Translational Stem Cell Research Conference, New York City Oct. 10 – 11 Epigenetics and Stem Cells 2012, Cambridge, UK Oct. 16 – 17, 2012 Texas Cures/ Texans for Stem Cell Research Education Mtg, Austin, Oct. 19 ISSCR-Roddenberry Symposium, Gladstone (San Fran), Oct. 24-25 Houston
2012 stem cell meetings and conferences Read More »
RNL Bio has been accused of allegedly smuggling stem cells out of Korea to treat patients in Japan and China without going through customs. But there is more trouble. RNL Bio faces additional challenges as reportedly (AsiaOne News) the Korean Government is weighing whether to charge RNL criminally based on their stem cell treatments being illegal
RNL Bio had a challenging year in 2012 in my opinion. It was sued in U.S. court for stem cell fraud by Korean national patients living in the U.S. It had a legal tussle, still ongoing, with former partner Celltex over custody of Celltex’s banked patient stem cells. Well, it seems to me that 2013
RNL Bio charges for alleged stem cell smuggling raise larger questions Read More »
For the second year in a row (see awards 2011), Advanced Cell Technology (ACT; stock symbol ACTC) is my stem cell biotech of the year. Their trials for different forms of macular degeneration (here and here and here) are progressing well and as a stem cell scientist I really appreciate the fact they are publishing their
Stem cell biotech of the year 2012: Advanced Cell Technology (ACTC) Read More »
Stem cell blogs make a big contribution to the stem cell world. Which is the best? It’s a tough choice. This year my pick is stemcellassays.com by Alexey Bersenev as 2012 Stem Cell Blog of the Year. You can also follow Alexey on Twitter here. Congrats to Alexey. Alexey’s blog consistently is outstanding in that it
Stem cell blog of the year 2012: stemcellassays.com by Alexey Bersenev Read More »